Bijoy Panicker

FDA investigator · also recorded as Of Tals Bijoy Panicker, Eae Bijoy Panicker

Appears on 34 documents from 2017 to 2025, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).

34
Documents on file
5.6
Observations per 483
2017
First seen
2025
Most recent

What they cite most

From 190 observations

Activity by year

2017: 1, 2018: 2, 2019: 5, 2020: 3, 2021: 3, 2022: 6, 2023: 4, 2024: 7, 2025: 3

Where

New York 17 · India 9 · Japan 3 · Greece 1 · Maryland 1 · Slovenia 1

Is Bijoy Panicker coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

34 documents, newest first
FirmOpen
483 Otsuka Pharmaceutical Co LtdJun 17, 2025 · KONIU, Japan
483 Astellas Pharma Inc.Jun 6, 2025 · Takaoka, Japan
483 Evaric Pharmaceuticals IncMay 16, 2025 · Hauppauge, New York
483 Apitoria Pharma Private LimitedDec 17, 2024 · Sangareddy, India
483 Symed Labs LimitedDec 6, 2024 · Sangareddy, India
483 Innogenix, LLCNov 15, 2024 · Amityville, New York
483 Ascent Pharmaceuticals IncAug 9, 2024 · Central Islip, New York

About this profile

What does Bijoy Panicker inspect?

Bijoy Panicker appears on 34 documents on file covering 30 sites, mostly in New York.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.68 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Bijoy Panicker is dated Jun 17, 2025.

FDA Investigator Bijoy Panicker: 483s & Inspections · FDA Intel